Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › CO › COLORADO SPRINGS › SUMMIT PRIMARY CARE

SUMMIT PRIMARY CARE

NPI: 1285256818 · COLORADO SPRINGS, CO 80910 · Family Medicine Physician · NPI assigned 05/18/2020

$10.27M
Total Medicaid Paid
341,129
Total Claims
295,357
Beneficiaries
139
Codes Billed
2020-09
First Month
2024-12
Last Month

Provider Details

Authorized OfficialPASSILLA, ELIZABETH (MANAGER)
NPI Enumeration Date05/18/2020

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 59,476 $922K
2021 149,901 $3.32M
2022 48,609 $2.20M
2023 60,588 $2.45M
2024 22,555 $1.38M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 20,407 18,520 $3.76M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 28,220 24,607 $1.84M
82075 21,407 18,924 $385K
96127 33,828 29,051 $311K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 6,052 5,322 $292K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 19,107 16,833 $279K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 208 191 $170K
83992 5,739 4,946 $101K
80371 5,739 4,946 $91K
80345 5,739 4,946 $91K
80357 5,739 4,946 $91K
80335 5,739 4,946 $91K
80332 5,739 4,946 $91K
80339 5,739 4,946 $91K
80342 5,739 4,946 $91K
80372 5,739 4,946 $91K
80329 5,739 4,946 $91K
80353 5,739 4,946 $91K
80368 5,739 4,946 $91K
80348 5,739 4,946 $91K
80373 5,739 4,946 $91K
80354 5,739 4,946 $91K
80355 5,739 4,946 $91K
80361 5,739 4,946 $91K
80338 5,739 4,946 $91K
80365 5,739 4,946 $91K
80366 5,739 4,946 $91K
80362 5,739 4,946 $91K
80360 5,739 4,946 $91K
80358 5,739 4,946 $91K
80359 5,738 4,946 $91K
80369 5,738 4,946 $91K
80356 5,738 4,945 $91K
80346 5,739 4,946 $91K
80324 5,738 4,945 $91K
80323 5,735 4,942 $91K
99215 Prolong outpt/office vis 471 410 $47K
87150 207 190 $46K
80367 2,476 2,130 $38K
80350 2,476 2,130 $38K
80349 2,455 2,110 $38K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 312 296 $37K
82652 675 634 $23K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 190 174 $19K
82172 873 419 $16K
G8510 Screening for depression is documented as negative, a follow-up plan is not required 1,501 1,313 $16K
82670 438 419 $11K
99205 Prolong outpt/office vis 58 57 $10K
99406 1,079 893 $9K
84443 Thyroid stimulating hormone (TSH) 611 578 $9K
84270 438 419 $9K
83036 Hemoglobin; glycosylated (A1C) 1,340 967 $8K
83001 468 448 $8K
84146 438 419 $8K
83002 439 419 $7K
83090 439 419 $7K
87529 207 190 $7K
87481 207 190 $7K
82607 502 478 $7K
86800 452 431 $7K
82533 438 419 $7K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1,002 893 $6K
86376 451 431 $6K
87641 207 190 $6K
81025 894 809 $6K
82746 439 419 $6K
84439 748 703 $6K
96136 324 277 $6K
96130 107 88 $6K
84480 473 456 $6K
82728 444 429 $6K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 68 66 $6K
87640 192 175 $5K
80061 Lipid panel 862 667 $5K
99497 214 193 $4K
94010 170 147 $4K
36415 Collection of venous blood by venipuncture 1,821 1,618 $4K
83550 439 419 $3K
87653 207 190 $3K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 207 190 $3K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 207 190 $3K
99401 168 153 $3K
83540 537 507 $3K
82977 450 431 $3K
87511 182 168 $3K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 182 168 $3K
83735 439 420 $3K
84144 131 124 $3K
83721 454 392 $2K
86431 410 391 $2K
86140 442 422 $2K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 57 43 $2K
82248 412 394 $2K
84550 439 419 $2K
84100 405 394 $2K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 59 50 $2K
82947 418 394 $1K
90688 109 105 $1K
84403 51 49 $1K
83970 31 29 $1K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 68 64 $1K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 26 26 $1K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 106 88 $977.49
20552 31 25 $968.40
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 12 12 $796.53
80053 Comprehensive metabolic panel 177 135 $781.78
97802 266 233 $672.97
90792 Psychiatric diagnostic evaluation with medical services 25 15 $629.88
82627 31 29 $622.44
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) 80 68 $577.81
84481 31 29 $474.32
80305 65 53 $473.86
84153 22 22 $404.58
84460 593 419 $224.83
82310 592 419 $224.05
82565 592 419 $222.31
84450 593 419 $219.74
82247 592 419 $212.95
84075 592 419 $211.74
84436 93 80 $206.10
86430 31 29 $171.92
84520 592 419 $171.51
84155 593 419 $155.68
82962 409 390 $136.45
86593 31 29 $114.40
99173 75 74 $104.62
82040 601 419 $66.38
99408 69 69 $65.52
J1885 Injection, ketorolac tromethamine, per 15 mg 74 60 $46.70
83718 610 420 $16.38
84478 608 419 $5.74
82465 608 419 $4.35
82374 608 419 $2.05
84295 608 419 $2.02
84132 608 419 $2.00
82435 608 419 $1.93
99493 24 19 $0.00
99492 19 12 $0.00
98960 72 60 $0.00